|
Jan 10
|
Could Regeneron Stock Help You Retire a Millionaire?
|
|
Jan 10
|
GSK to Buy Private Biotech, Strengthen Respiratory Pipeline
|
|
Jan 9
|
Regeneron (REGN) Down as Q4 Eylea Preliminary Sales Disappoint
|
|
Jan 7
|
Is Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) Latest Stock Performance Being Led By Its Strong Fundamentals?
|
|
Jan 5
|
Regeneron to Report Fourth Quarter and Full Year 2023 Financial and Operating Results and Host Conference Call and Webcast on February 2, 2024
|
|
Jan 5
|
3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024
|
|
Jan 4
|
Powerful Inflows Send Regeneron Shares Surging
|
|
Jan 4
|
Intellia to lay off staff, cut some early research
|
|
Jan 4
|
Are Medical Stocks Lagging Aclaris Therapeutics (ACRS) This Year?
|
|
Jan 4
|
2 Healthcare Stocks That Turned $1,000 Into $2,400 (or More)
|
|
Jan 4
|
5 FDA decisions to watch in the first quarter
|
|
Jan 3
|
Earnings Estimates Moving Higher for Regeneron (REGN): Time to Buy?
|
|
Jan 3
|
Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?
|
|
Jan 3
|
Top 5 Momentum Picks for January After a Fabulous 2023
|
|
Jan 3
|
Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 50% Undervaluation?
|
|
Dec 27
|
Regeneron Gains After Eye-Drug Patent Victory Over Viatris
|
|
Dec 22
|
Where Will Regeneron Pharmaceuticals Be in 1 Year?
|
|
Dec 22
|
These 4 Measures Indicate That Regeneron Pharmaceuticals (NASDAQ:REGN) Is Using Debt Reasonably Well
|
|
Dec 19
|
The Zacks Analyst Blog Highlights Novo Nordisk, Eli Lilly, Vertex Pharmaceuticals, Regeneron and GSK
|
|
Dec 18
|
Regeneron Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
|